Key statistics
On Friday, Kronos Bio Inc (KRON:NSQ) closed at 1.03, 49.28% above the 52 week low of 0.69 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.95 |
---|---|
High | 1.03 |
Low | 0.95 |
Bid | 0.9722 |
Offer | 1.01 |
Previous close | 0.9476 |
Average volume | 93.76k |
---|---|
Shares outstanding | 60.29m |
Free float | 44.07m |
P/E (TTM) | -- |
Market cap | 62.10m USD |
EPS (TTM) | -1.75 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Kronos Bio Announces Participation in Medical and Investor Conferences in September
- Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update
- Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer
- Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
- Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
- Kronos Bio Reports First-Quarter 2024 Financial Results
- Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results
- Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway
- Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting
More ▼